1179149-25-7

Basic information

• Product Name: 4-BroMoisoquinoline-1-carboxylic acid
• Synonyms: 4-BroMoisoquinoline-1-carboxylic acid
• CAS NO: 1179149-25-7
• Molecular Formula: C10H6BrNO2
• Molecular Weight: 252.06414
• Mol File: 1179149-25-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-BroMoisoquinoline-1-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMoisoquinoline-1-carboxylic acid(1179149-25-7)
• EPA Substance Registry System: 4-BroMoisoquinoline-1-carboxylic acid(1179149-25-7)

Safety Data

• Hazardous Substances Data: 1179149-25-7(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-Bromoisoquinoline-1-carboxylic acid is used as a key intermediate in organic synthesis for the preparation of a variety of chemical compounds. Its reactive bromine and carboxylic acid groups facilitate multiple synthetic transformations, making it a useful precursor for the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-bromoisoquinoline-1-carboxylic acid is employed as a versatile building block for the development of bioactive molecules. Its unique structure and functional groups allow for the design and synthesis of novel drug candidates with potential therapeutic applications.
Used in Drug Development:
4-Bromoisoquinoline-1-carboxylic acid is utilized in drug development as a starting material for the synthesis of new pharmaceutical compounds. Its chemical properties and reactivity enable the creation of diverse drug candidates with potential applications in various therapeutic areas.
Used in Agrochemical Industry:
In the agrochemical sector, 4-bromoisoquinoline-1-carboxylic acid is used as a chemical intermediate for the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure and functional groups contribute to the development of effective and environmentally friendly agrochemical products.
Used in Materials Industry:
4-Bromoisoquinoline-1-carboxylic acid also finds applications in the materials industry, where it is used as a building block for the synthesis of advanced materials with specific properties. Its chemical versatility allows for the development of materials with potential applications in various fields, such as electronics, coatings, and polymers.

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or Formula (II) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.